155 related articles for article (PubMed ID: 8898977)
1. MDR1 expression correlates with mutant p53 expression in colorectal cancer metastases.
de Kant E; Heide I; Thiede C; Herrmann R; Rochlitz CF
J Cancer Res Clin Oncol; 1996; 122(11):671-5. PubMed ID: 8898977
[TBL] [Abstract][Full Text] [Related]
2. P-glycoprotein is not expressed in a majority of colorectal carcinomas and is not regulated by mutant p53 in vivo.
De Angelis P; Stokke T; Smedshammer L; Lothe RA; Lehne G; Chen Y; Clausen OP
Br J Cancer; 1995 Aug; 72(2):307-11. PubMed ID: 7640210
[TBL] [Abstract][Full Text] [Related]
3. P-glycoprotein is positively correlated with p53 protein accumulation in human colorectal cancers.
Oka M; Kounoura K; Narasaki F; Sakamoto A; Fukuda M; Matsuo I; Ikeda K; Tsurutani J; Ikuno N; Omagari K; Mizuta Y; Soda H; Gudas JM; Kohno S
Jpn J Cancer Res; 1997 Aug; 88(8):738-42. PubMed ID: 9330605
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors.
Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS
J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219
[TBL] [Abstract][Full Text] [Related]
5. Mutant p53 cooperates with ETS and selectively up-regulates human MDR1 not MRP1.
Sampath J; Sun D; Kidd VJ; Grenet J; Gandhi A; Shapiro LH; Wang Q; Zambetti GP; Schuetz JD
J Biol Chem; 2001 Oct; 276(42):39359-67. PubMed ID: 11483599
[TBL] [Abstract][Full Text] [Related]
6. MDR1 RNA transcripts do not indicate long-term prognosis in colorectal carcinomas.
Zöchbauer S; Wallner J; Haider K; Depisch D; Huber H; Pirker R
Eur J Cancer; 1997 Aug; 33(9):1516-8. PubMed ID: 9337699
[TBL] [Abstract][Full Text] [Related]
7. p53-dependent regulation of MDR1 gene expression causes selective resistance to chemotherapeutic agents.
Thottassery JV; Zambetti GP; Arimori K; Schuetz EG; Schuetz JD
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):11037-42. PubMed ID: 9380755
[TBL] [Abstract][Full Text] [Related]
8. Association of p53 mutations, microvessel density and neoangiogenesis in pairs of colorectal cancers and corresponding liver metastases.
Kern A; Taubert H; Scheele J; Rudroff C; Mothes H; Kappler M; Bartel F; Richter KK
Int J Oncol; 2002 Aug; 21(2):243-9. PubMed ID: 12118317
[TBL] [Abstract][Full Text] [Related]
9. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53.
Chin KV; Ueda K; Pastan I; Gottesman MM
Science; 1992 Jan; 255(5043):459-62. PubMed ID: 1346476
[TBL] [Abstract][Full Text] [Related]
10. Reversal of 5-flouroucial resistance by adenovirus-mediated transfer of wild-type p53 gene in multidrug-resistant human colon carcinoma LoVo/5-FU cells.
Yu ZW; Zhao P; Liu M; Dong XS; Tao J; Yao XQ; Yin XH; Li Y; Fu SB
World J Gastroenterol; 2004 Jul; 10(13):1979-83. PubMed ID: 15222051
[TBL] [Abstract][Full Text] [Related]
11. Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer.
Rybárová S; Vecanová J; Hodorová I; Mihalik J; Čižmáriková M; Mojžiš J; Solár P; Benický M; Adamkov M; Mirossay L
Med Sci Monit; 2011 Dec; 17(12):BR354-63. PubMed ID: 22129893
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the Mdr1 isoforms in a p53-deficient mouse model.
Bush JA; Li G
Carcinogenesis; 2002 Oct; 23(10):1603-7. PubMed ID: 12376467
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological associations with p53 tumour-suppressor gene mutations and expression of p21WAF1/Cip1 in colorectal carcinoma.
Slebos RJ; Baas IO; Clement M; Polak M; Mulder JW; van den Berg FM; Hamilton SR; Offerhaus GJ
Br J Cancer; 1996 Jul; 74(2):165-71. PubMed ID: 8688317
[TBL] [Abstract][Full Text] [Related]
14. Relationship between P-glycoprotein expression and p53 status in high-grade osteosarcoma.
Serra M; Maurici D; Scotlandi K; Barbanti-Brodano G; Manara MC; Benini S; Picci P; Bertoni F; Bacci G; Sottili S; Baldini N
Int J Oncol; 1999 Feb; 14(2):301-7. PubMed ID: 9917506
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a mutual regulation of p53 and c-myc expression in human colorectal cancer metastases.
Rochlitz CF; Heide I; Thiede C; Herrmann R; de Kant E
Ann Oncol; 1995 Dec; 6(10):981-6. PubMed ID: 8750149
[TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance related genes and p53 expression in human non small cell lung cancer.
Galimberti S; Marchetti A; Buttitta F; Carnicelli V; Pellegrini S; Bevilacqua G; Petrini M
Anticancer Res; 1998; 18(4C):2973-6. PubMed ID: 9713494
[TBL] [Abstract][Full Text] [Related]
17. Preferential expression of a mutant allele of the amplified MDR1 (ABCB1) gene in drug-resistant variants of a human sarcoma.
Chen KG; Lacayo NJ; Durán GE; Wang Y; Bangs CD; Rea S; Kovacs M; Cherry AM; Brown JM; Sikic BI
Genes Chromosomes Cancer; 2002 Aug; 34(4):372-83. PubMed ID: 12112526
[TBL] [Abstract][Full Text] [Related]
18. Tamoxifen can reverse multidrug resistance of colorectal carcinoma in vivo.
Shen LZ; Hua YB; Yu XM; Xu Q; Chen T; Wang JH; Wu WX
World J Gastroenterol; 2005 Feb; 11(7):1060-4. PubMed ID: 15742416
[TBL] [Abstract][Full Text] [Related]
19. The role of P-glycoprotein (MDR1) polymorphisms and mutations in colorectal cancer.
Potocnik U; Glavac MR; Golouh R; Glavac D
Pflugers Arch; 2001; 442(6 Suppl 1):R182-3. PubMed ID: 11678332
[TBL] [Abstract][Full Text] [Related]
20. Naturally occurring mutations and functional polymorphisms in multidrug resistance 1 gene: correlation with microsatellite instability and lymphoid infiltration in colorectal cancers.
Potocnik U; Ravnik-Glavac M; Golouh R; Glavac D
J Med Genet; 2002 May; 39(5):340-6. PubMed ID: 12011154
[No Abstract] [Full Text] [Related]
[Next] [New Search]
